Evidence map›Paper›PMID 39580523›Full record

ArticleScientific reports2024

The intrahepatic bacterial metataxonomic signature of patients with hepatocellular carcinoma.

Jie Li, Xuanpei Zhai, Changzhou Chen, Rong Zhang, Xiaowu Huang, Yifan Liu

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie Li *School of Physical Science and Technology, ShanghaiTech University, Shanghai, China.
Xuanpei Zhai *School of Physical Science and Technology, ShanghaiTech University, Shanghai, China.
Changzhou ChenDepartment of Liver Surgery and Transplantation, Zhongshan Hospital, Liver Cancer Institute, Fudan University, Shanghai, China.
Rong ZhangSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, China. zhangrong1@shanghaitech.edu.cn.
Xiaowu HuangDepartment of Liver Surgery and Transplantation, Zhongshan Hospital, Liver Cancer Institute, Fudan University, Shanghai, China. huang.xiaowu@zs-hospital.sh.cn.
Yifan LiuSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, China. liuyf6@shanghaitech.edu.cn.

Funding

Shanghai Science and Technology Committee 23QA1406600the National Natural Science Foundation of China 32300081
6 · The paper itself

Abstract

Dysbiosis of the gut-liver axis increases the risk of bacterial and metabolite influx into the liver, which may contribute to the development of hepatocellular carcinoma (HCC). In this study, we compared the microbiomes in HCC tumors and adjacent tissues. We examined the HCC tumors and adjacent tissues from 19 patients diagnosed with HCC. We find that the liver tissues from HCC patients with capsule invasion presented higher alpha diversity at the genus level than those without. The bacterial compositions in liver tissues of HCC patients at stage II differed from those at stage I and Advanced, respectively. Metagenomic profiling revealed that order Actinomycetales was enriched in the HCC patients at advanced stages. Order Lactobacillales, family Veillonellaceae, genera Rhodobacter and Megasphaera are enriched in tumors of HCC patients, whereas genus Pseudochrobactrum is enriched in the adjacent tissues from HCC patients. An increased abundance of class Actinobacteria and order Actinomycetales is observed in the HCC patients with cirrhosis. In contrast, phylum Firmicutes, classes Clostridia and Betaproteobacteria, and order Clostridiales are enriched in those without cirrhosis. The presence of various types of bacterial 16S rRNAs in HCC tumors and adjacent tissues indicates the presence of various bacterial communities therein. Our study provides information about differentially abundant intrahepatic bacteria in patients with HCC. The differences found may support possible diagnostic and personalized therapeutic implications for HCC.

Indexed as

BacteriaCarcinoma, HepatocellularLiver NeoplasmsAdultAgedFemaleHumansLiverLiver CirrhosisMaleMetagenomicsMicrobiotaMiddle AgedRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNA gene analysisGut-liver axisHepatocellular carcinomaIntrahepatic microbiomeTumor microbiota

Identifiers

PMID39580523
PMCPMC11585554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.